Stocks · News reference

IceCure Medical Announces That The Society Of Interventional Oncology Submitted A Petition To The National Comprehensive Cancer Network Breast Cancer Guidelines Panel To Include Percutaneous Cryoablation Without Surgical Excision As An Option For Breast Cancer

Jul 29, 2026, 12:30 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 6, 2026, 12:29 PMBenzinga Newsdesk
IceCure Medical Adds Legacy Health In Portland, Oregon, As New U.S. Clinical Site For Its Post-Marketing ChoICE Study Evaluating Prosense Cryoablation For Treatment Of Low-Risk Breast Cancer
Adds Legacy Health in Portland, Oregon, with its Legacy Medical Group–Surgical Oncology at Good Samaritan Medical Center , as a new U.S. clinical site for its post-marketing study (the "ChoICE Study") evaluating
ICCM
BenzingaSep 18, 2026, 11:09 AMBenzinga Insights
Full Transcript: Icecure Medical Q2 2026 Earnings Call
Icecure Medical (NASDAQ:ICCM) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial
ICCM
BenzingaSep 10, 2026, 12:01 PMBenzinga Newsdesk
IceCure Medical Receives Approval From China's National Medical Products Administration For Its ProSense System, Associated Cryoprobes
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
ICCM
BenzingaAug 24, 2026, 11:51 AMBenzinga Newsdesk
IceCure Medical Inks Distribution Agreement With Scovas Medical To Distribute IceCure's ProSense Cryoablation Systems In Netherlands
ICCM